QDEL1 * logo

QuidelOrtho BMV:QDEL1 * Stock Report

Last Price

Mex$1.15k

Market Cap

Mex$51.8b

7D

0%

1Y

n/a

Updated

04 Mar, 2024

Data

Company Financials +

QuidelOrtho Corporation

BMV:QDEL1 * Stock Report

Market Cap: Mex$51.8b

QDEL1 * Stock Overview

QuidelOrtho Corporation provides diagnostic testing solutions.

QDEL1 * fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance0/6
Financial Health1/6
Dividends0/6

QuidelOrtho Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for QuidelOrtho
Historical stock prices
Current Share PriceUS$1,154.00
52 Week HighUS$1,154.00
52 Week LowUS$1,154.00
Beta0.11
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change-63.67%
5 Year Changen/a
Change since IPO-66.70%

Recent News & Updates

Recent updates

Shareholder Returns

QDEL1 *MX Medical EquipmentMX Market
7D0%0%0%
1Yn/a0%0%

Return vs Industry: Insufficient data to determine how QDEL1 * performed against the MX Medical Equipment industry.

Return vs Market: Insufficient data to determine how QDEL1 * performed against the MX Market.

Price Volatility

Is QDEL1 *'s price volatile compared to industry and market?
QDEL1 * volatility
QDEL1 * Average Weekly Movementn/a
Medical Equipment Industry Average Movement0%
Market Average Movement0%
10% most volatile stocks in MX Market0%
10% least volatile stocks in MX Market0%

Stable Share Price: QDEL1 * has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine QDEL1 *'s volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19797,000Mike Iskrahttps://www.quidelortho.com

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.

QuidelOrtho Corporation Fundamentals Summary

How do QuidelOrtho's earnings and revenue compare to its market cap?
QDEL1 * fundamental statistics
Market capMex$51.80b
Earnings (TTM)-Mex$171.89m
Revenue (TTM)Mex$51.02b

1.0x

P/S Ratio

-301.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
QDEL1 * income statement (TTM)
RevenueUS$3.00b
Cost of RevenueUS$1.50b
Gross ProfitUS$1.49b
Other ExpensesUS$1.50b
Earnings-US$10.10m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.15
Gross Margin49.85%
Net Profit Margin-0.34%
Debt/Equity Ratio48.4%

How did QDEL1 * perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.